TR200907227A2 - Çözünürlüğü yüksek stabil mikronize granüller. - Google Patents

Çözünürlüğü yüksek stabil mikronize granüller.

Info

Publication number
TR200907227A2
TR200907227A2 TR2009/07227A TR200907227A TR200907227A2 TR 200907227 A2 TR200907227 A2 TR 200907227A2 TR 2009/07227 A TR2009/07227 A TR 2009/07227A TR 200907227 A TR200907227 A TR 200907227A TR 200907227 A2 TR200907227 A2 TR 200907227A2
Authority
TR
Turkey
Prior art keywords
high solubility
stable micronized
micronized granules
granules
stable
Prior art date
Application number
TR2009/07227A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2009/07227A priority Critical patent/TR200907227A2/tr
Priority to PCT/TR2010/000181 priority patent/WO2011034514A2/en
Publication of TR200907227A2 publication Critical patent/TR200907227A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Abstract

Mevcut buluş, çözünürlük ve stabilite özellikleri geliştirilmiş moksifloksasin bileşimlerine, bu bileşimlerin hazırlanma yöntemine ve tıbbi kullanımına ilişkindir.
TR2009/07227A 2009-09-18 2009-09-18 Çözünürlüğü yüksek stabil mikronize granüller. TR200907227A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2009/07227A TR200907227A2 (tr) 2009-09-18 2009-09-18 Çözünürlüğü yüksek stabil mikronize granüller.
PCT/TR2010/000181 WO2011034514A2 (en) 2009-09-18 2010-09-06 Stable micronized granules having high solubility

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2009/07227A TR200907227A2 (tr) 2009-09-18 2009-09-18 Çözünürlüğü yüksek stabil mikronize granüller.

Publications (1)

Publication Number Publication Date
TR200907227A2 true TR200907227A2 (tr) 2011-04-21

Family

ID=43759215

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2009/07227A TR200907227A2 (tr) 2009-09-18 2009-09-18 Çözünürlüğü yüksek stabil mikronize granüller.

Country Status (2)

Country Link
TR (1) TR200907227A2 (tr)
WO (1) WO2011034514A2 (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1106900A2 (pt) * 2011-12-26 2013-11-05 Ems Sa Composição farmacêutica sólida compreendendo antibótico da familia das quinolonas e processo de sua obtenção
GR1008169B (el) * 2013-03-19 2014-04-08 "Φαρματεν Α.Β.Ε.Ε.", Φαρμακευτικο σκευασμα περιεχον εναν αντιβακτηριακο παραγοντα φθοριοκινολονης και μεθοδος για την παρασκευη αυτου
JP7074963B2 (ja) 2017-01-31 2022-05-25 ヴェル インコーポレイテッド ゴナドトロピン放出ホルモン（ＧｎＲＨ）拮抗薬の長期放出のための組成物および方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ292069B6 (cs) * 1998-11-10 2003-07-16 Bayer Aktiengesellschaft Farmaceutický přípravek zahrnující moxifloxacin, způsob výroby a použití tohoto přípravku
EP2291177A2 (en) * 2008-05-05 2011-03-09 Farmaprojects, S.A. Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale
ES2391132T3 (es) * 2008-10-09 2012-11-21 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Uso de disolventes orgánicos en la granulación húmeda de moxifloxacino

Also Published As

Publication number Publication date
WO2011034514A2 (en) 2011-03-24
WO2011034514A3 (en) 2011-11-10

Similar Documents

Publication Publication Date Title
CY1122853T1 (el) Σταθερα σκευασματα λινακλοτιδης
JOP20180102B1 (ar) مركب صيدلاني
EP3216448B8 (en) Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MA32383B1 (fr) DÉRIVÉS D'INDAZOLES à SUBSTITUTIONS PHÉNYLE ET BENZODIOXYNYLE
UA108105C2 (ru) Азотсодержащие гетероарильные соединения
IN2014MN02598A (tr)
UA109010C2 (en) MORPHOLINOPYRIMIDINES AND THEIR APPLICATIONS IN THERAPY
MX2016008448A (es) Conjugados de var2csa-farmaco.
UA111717C2 (uk) Склад для перорального введення і ліпофільні солі метилналтрексону
MX2019012939A (es) Formulaciones que contienen linaclotida para administracion oral.
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
UA109037C2 (uk) Триазолопіридини
MX340983B (es) Composiciones farmaceuticas y nutraceuticas de acido abscisico.
UA115357C2 (uk) Похідні піридин-4-ілу
MX2013006418A (es) Derivados de oxazolil-metileter como agonistas del receptor de alx.
UA104420C2 (uk) Застосування похідних глутарової кислоти або їх фармацевтично прийнятних солей як протиаритмічних засобів
MY178583A (en) Hydantoin derivative
TR200907227A2 (tr) Çözünürlüğü yüksek stabil mikronize granüller.
IN2012DN01223A (tr)
TR200909785A1 (tr) Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar.
MX2015005510A (es) Forma salina solida de la alfa-6-mpeg6-o-hidroxicodona como agonistas opioides y sus usos.
MX2013005624A (es) Nuevos derivados de indolizina, su preparacion y su aplicacion en terapeutica.
TR200906322A2 (tr) Çözünürlük ve stabilite özellikleri geliştirilmiş granüller.
UA92872C2 (ru) Комбинированное антиагрегантное и антиоксидантное лекарственное средство